Paolo Fundaro, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 324 shares at $239.49 ($78K) on 2014-08-11, disclosed to the SEC on 2014-08-12.
Scheduled sale ($78k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-03-29 | $467K | — | Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-05-09 | $75K | — | Filing → |